These effects, along with a preceding report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,two support the notion of targeting ACKR3 as a unique approach to modulate the opioid method, which could open new therapeutic avenues for opioid-linked Conditions.(two) The health practitioner has received a writt